These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37188987)

  • 21. Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma.
    Minami Y; Aoki T; Hagiwara S; Kudo M
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiomics Model Based on Gadoxetic Acid Disodium-Enhanced MR Imaging to Predict Hepatocellular Carcinoma Recurrence After Curative Ablation.
    Zhang L; Cai P; Hou J; Luo M; Li Y; Jiang X
    Cancer Manag Res; 2021; 13():2785-2796. PubMed ID: 33790652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma.
    Li XQ; Wang X; Zhao DW; Sun J; Liu JJ; Lin DD; Yang G; Liu H; Xia ZY; Jia CY; Li HJ
    World J Surg Oncol; 2020 Aug; 18(1):219. PubMed ID: 32828123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer.
    Qi X; Li G; Liu D; Motamarry A; Huang X; Wolfe AM; Helke KL; Haemmerich D; Staveley-O'Carroll KF; Kimchi ET
    Cancer Biol Ther; 2015; 16(12):1812-9. PubMed ID: 26537481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fusion of Preinterventional MR Imaging With Liver Perfusion CT After RFA of Hepatocellular Carcinoma: Early Quantitative Prediction of Local Recurrence.
    Kobe A; Kindler Y; Klotz E; Puippe G; Messmer F; Alkadhi H; Pfammatter T
    Invest Radiol; 2021 Mar; 56(3):188-196. PubMed ID: 32932379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Machine Learning-Based Radiomic Features on Pre-Ablation MRI as Predictors of Pathologic Response in Patients with Hepatocellular Carcinoma Who Underwent Hepatic Transplant.
    Tabari A; D'Amore B; Cox M; Brito S; Gee MS; Wehrenberg-Klee E; Uppot RN; Daye D
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.
    Kikuchi L; Menezes M; Chagas AL; Tani CM; Alencar RS; Diniz MA; Alves VA; D'Albuquerque LA; Carrilho FJ
    World J Gastroenterol; 2014 Feb; 20(6):1585-93. PubMed ID: 24587635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging.
    Kim SM; Shin SS; Lee BC; Kim JW; Heo SH; Lim HS; Jeong YY
    Abdom Radiol (NY); 2017 Oct; 42(10):2527-2537. PubMed ID: 28409202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial.
    Seidensticker M; Öcal O; Schütte K; Malfertheiner P; Berg T; Loewe C; Klümpen HJ; van Delden O; Ümütlü MR; Ben Khaled N; de Toni EN; Seidensticker R; Aghdassi A; Tran A; Bronowicki JP; Peynircioglu B; Sangro B; Pech M; Ricke J
    JHEP Rep; 2023 May; 5(5):100699. PubMed ID: 36968218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous radiofrequency ablation for small hepatocellular carcinoma in hepatic dome under MR-guidance: clinical safety and efficacy.
    Chen J; Lin Z; Lin Q; Lin R; Yan Y; Chen J
    Int J Hyperthermia; 2020; 37(1):192-201. PubMed ID: 32066293
    [No Abstract]   [Full Text] [Related]  

  • 31. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.
    Feng ST; Jia Y; Liao B; Huang B; Zhou Q; Li X; Wei K; Chen L; Li B; Wang W; Chen S; He X; Wang H; Peng S; Chen ZB; Tang M; Chen Z; Hou Y; Peng Z; Kuang M
    Eur Radiol; 2019 Sep; 29(9):4648-4659. PubMed ID: 30689032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI.
    Schelhorn J; Best J; Reinboldt MP; Dechêne A; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
    J Magn Reson Imaging; 2015 Sep; 42(3):818-27. PubMed ID: 25515676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma.
    Xu Z; Xie H; Zhou L; Chen X; Zheng S
    Anal Cell Pathol (Amst); 2019; 2019():8619096. PubMed ID: 31534899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of Radiofrequency Ablation, Microwave Ablation, and Irreversible Electroporation by Using Propensity Score Analysis for Early Stage Hepatocellular Carcinoma.
    Wada T; Sugimoto K; Sakamaki K; Takahashi H; Kakegawa T; Tomita Y; Abe M; Yoshimasu Y; Takeuchi H; Itoi T
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial.
    Kamal A; Elmoety AAA; Rostom YAM; Shater MS; Lashen SA
    J Gastrointest Oncol; 2019 Jun; 10(3):562-571. PubMed ID: 31183208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].
    Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma.
    Zhu Y; Weng S; Li Y; Yan C; Ye R; Wen L; Zhou L; Gao L
    Abdom Radiol (NY); 2021 Jul; 46(7):3139-3148. PubMed ID: 33641018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study.
    Wang JH; Chen TY; Ou HY; Wang CC; Liu YW; Hung CH; Chen CH; Kuo CH; Hu TH; Cheng YF; Lu SN
    Dig Dis Sci; 2016 Apr; 61(4):1197-205. PubMed ID: 26668057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative MRI for Assessment of Treatment Outcomes in a Rabbit VX2 Hepatic Tumor Model.
    Keller S; Chapiro J; Brangsch J; Reimann C; Collettini F; Sack I; Savic LJ; Hamm B; Goldberg SN; Makowski M
    J Magn Reson Imaging; 2020 Sep; 52(3):668-685. PubMed ID: 31713973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumor ghost on MRI after microwave ablation for hepatocellular carcinoma: A new modality to assess the ablative margin.
    Liu S; Wu J; Ding W; Zhang C; Luo Y; Bai X; Wen K; Han Z; Yu J; Liang P
    Eur J Radiol; 2023 Jan; 158():110617. PubMed ID: 36463706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.